Author:
Bartlett Nancy L.,Johnson Jeffrey L.,Wagner-Johnston Nina,Ratain Mark J.,Peterson Bruce A.,
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference22 articles.
1. Ohno R, Okada K, Masaoka T et al (1990) An early Phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma. J Clin Oncol 8(11):1907–1912
2. Ota K, Ohna R, Shirakawa S et al (1994) Late Phase II study of irinotecan hydrochloride (CPT-11) in the treatment of malignant lymphoma and acute leukemia. The CPT-11 Research Group for Hematologic Malignancies. Japanese J Ca Chemoth 21(7):1047–1055 (Japanese)
3. Sarris AH, Romaguera J, Hagemeister FB et al (2001) Irinotecan in relapsed or refractory non-Hodgkins lymphoma. Oncology (Williston Park) 15(7 Suppl 8):53–56
4. Kraut EH, Balcerzak SP, Young D et al (2002) A phase II study of topotecan in non-Hodgkin’s lymphoma: an Ohio State University phase 2 consortium study. Cancer Invest 20(8):174–179
5. Younes A, Preti HA, Hagemeister FB et al (2001) Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma. Ann Oncol 12(7):923–927
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献